NIH Smuggling Case Exposes Cracks in U.S. Biosafety Enforcement

Two foreign nationals at the National Institutes of Health face federal charges for smuggling deactivated mpox vials from Africa and lying to authorities—a breach that exposes how fragile biosafety oversight truly is. The Select Agent Program depends on institutional self-reporting and researcher compliance. When insiders circumvent those mechanisms, the entire enforcement architecture shows its limits. Federal inspection capacity is already stretched thin, and investigators can't be everywhere. That gap matters when researchers with access to pandemic-level pathogens decide the rules don't apply to them.